The FDA has cleared a second carcass-feasting fly species, Lucilia cuprina, for maggot wound therapy. Cuprina Holdings now holds FDA clearance for two species, aiming to dominate the global maggot market.
Maggot therapy, FDA-approved in 2004, uses maggots to dissolve dead infected tissue in serious wounds, offering an alternative to surgery. Experts call them 'nature's microsurgeons,' though it's often a last resort.
Maggot therapy, approved by the FDA in 2004, uses maggots to dissolve dead infected tissue in serious wounds, acting as "nature's microsurgeons." Doctors often turn to this treatment when other methods fail, as it can be less invasive than surgery and avoids the need for anesthesia.
